IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group

✍ Scribed by M. Feuring-Buske; M. Kneba; M. Unterhalt; A. Engert; M. Gramatzki; E. Hiller; L. Trümper; W. Brugger; H. Ostermann; J. Atzpodien; M. Hallek; E. Aulitzky; W. Hiddemann

• Publisher: Springer
• Year: 2000
• Tongue: English
• Weight: 90 KB
• Volume: 79
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s002770000163